{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:57:18Z","timestamp":1793969838780,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Beijing Research Ward Excellence Program"},{"name":"Beijing Natural Science Foundation"},{"name":"the High-Level Public Health Specialized Talents Project of Beijing Municipal Health Commission"},{"name":"the National Key R&D Program of China"},{"name":"the Beijing Key Laboratory for HIV\/AIDS Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02985-3","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:13:29Z","timestamp":1762521209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["HIV-1 drug resistance and molecular transmission network analysis of newly diagnosed people living with HIV in Beijing, China: a retrospective study from 2015 to 2023"],"prefix":"10.1186","volume":"22","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2985_CR1","unstructured":"Global UNAIDS. May HIV & AIDS statistics fact - sheet. Accessed 30 May 2024. https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"2985_CR2","first-page":"225","volume":"31","author":"Center for STD\/AIDS Prevention and Control, Chinese Center for Disease Control and Prevention (CDC)","year":"2025","unstructured":"Center for STD\/AIDS Prevention and Control, Chinese Center for Disease Control and Prevention (CDC). National AIDS STD epidemic, December 2024. Chin J AIDS STD. 2025;31:225.","journal-title":"Chin J AIDS STD"},{"key":"2985_CR3","unstructured":"Beijing center for disease prevention and control. Report on AIDS epidemic situation in Beijing in 2023. Accessed 21 May 2024. https:\/\/wjw.beijing.gov.cn\/xwzx_20031\/mtjj\/202311\/t20231127_3309855.html"},{"key":"2985_CR4","first-page":"440","volume":"124","author":"L Luo","year":"2011","unstructured":"Luo L, Li TS. Overview of antiretroviral treatment in China: advancement and challenges. Chin Med J. 2011;124:440\u20134.","journal-title":"Chin Med J"},{"key":"2985_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/590945","volume":"47","author":"FJ Zhang","year":"2008","unstructured":"Zhang FJ, Dou ZH, Yu L, Xu JH, Jiao JH, Wang N, et al. The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China. Clin Infect Dis. 2008;47:825\u201333.","journal-title":"Clin Infect Dis"},{"key":"2985_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.7326\/0003-4819-151-4-200908180-00006","volume":"151","author":"FJ Zhang","year":"2009","unstructured":"Zhang FJ, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National free antiretroviral treatment program. Ann Intern Med. 2009;151:241\u201351.","journal-title":"Ann Intern Med"},{"key":"2985_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.851117","volume":"10","author":"QS Chen","year":"2022","unstructured":"Chen QS, Liu J, Fu XB, Yang F, Liu QC, Li JB, et al. Effect of late testing and antiretroviral treatment on mortality among people living with HIV in the era of treat-all in Guangdong province, China, 1992\u20132018: a cohort study. Front Public Health. 2022;10:851117.","journal-title":"Front Public Health"},{"key":"2985_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41051-w","volume":"14","author":"XS Wu","year":"2023","unstructured":"Wu XS, Wu GH, Ma P, Wang RG, Li LH, Chen YY, et al. Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China. Nat Commun. 2023;14:5334.","journal-title":"Nat Commun"},{"key":"2985_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00668-5","volume":"9","author":"RH Kang","year":"2020","unstructured":"Kang RH, Liang SJ, Ma YL, Liang S, Xiao L, Zhang XH, et al. Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017. Infect Dis Poverty. 2020;9:54.","journal-title":"Infect Dis Poverty"},{"key":"2985_CR10","doi-asserted-by":"publisher","DOI":"10.2196\/50894","volume":"9","author":"HL Chen","year":"2023","unstructured":"Chen HL, Hao JJ, Hu J, Song C, Zhou YS, Li MM, et al. Pretreatment HIV drug resistance and the molecular transmission network among HIV-positive individuals in China in 2022: multicenter observational study. JMIR Public Health Surveill. 2023;9:e50894.","journal-title":"JMIR Public Health Surveill"},{"key":"2985_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010115","volume":"17","author":"YZ Shi","year":"2024","unstructured":"Shi YZ, Huang HH, Wang XH, Song B, Jiang TJ, Yu MR, et al. Retrospective study on genetic diversity and drug resistance among people living with HIV at an AIDS clinic in Beijing. Pharmaceuticals (Basel). 2024;17:115.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2985_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3927-1","volume":"19","author":"ZY Wang","year":"2019","unstructured":"Wang ZY, Zhang M, Zhang RF, Liu L, Shen YZ, Wang JR, et al. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China. BMC Infect Dis. 2019;19:313.","journal-title":"BMC Infect Dis"},{"key":"2985_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.688292","volume":"12","author":"F Zhang","year":"2021","unstructured":"Zhang F, Liang BY, Liang X, Lin ZS, Yang Y, Liang N, et al. Using molecular transmission networks to reveal the epidemic of pretreatment HIV-1 drug resistance in Guangxi, China. Front Genet. 2021;12:688292.","journal-title":"Front Genet"},{"issue":"Suppl 1","key":"2985_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/hiv.13252","volume":"23","author":"LY Gao","year":"2022","unstructured":"Gao LY, Xia H, Zeng R, Wu Y, Zaongo SD, Hu Y, et al. Pretreatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China. HIV Med. 2022;23(Suppl 1):84\u201394.","journal-title":"HIV Med"},{"key":"2985_CR15","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2147\/DDDT.S406255","volume":"17","author":"H Xia","year":"2023","unstructured":"Xia H, Jin J, Ba H, Zhang Y, Li J, Guo R, et al. Genetic diversity and characteristics of drug resistance among treatment-naive people living with HIV in xi\u2019 an, China. Drug Des Devel Ther. 2023;17:1485\u201394.","journal-title":"Drug Des Devel Ther"},{"key":"2985_CR16","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1093\/jac\/dkae260","volume":"79","author":"ZQ Wang","year":"2024","unstructured":"Wang ZQ, Jiang H, Pang XW, Li JJ, Liang SJ, Huang JH, et al. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022. J Antimicrob Chemother. 2024;79:2575\u201385.","journal-title":"J Antimicrob Chemother"},{"key":"2985_CR17","first-page":"162","volume":"28","author":"DF Yuan","year":"2022","unstructured":"Yuan DF, Yin YQ, Chen JS, Zhou Y, Lu J, Fu GF, et al. Drug resistance in na\u00efve HIV\/AIDS virological treatment-failed population in china: A Meta-analysis. Chin J AIDS STD. 2022;28:162\u20137.","journal-title":"Chin J AIDS STD"},{"key":"2985_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jac\/dkad370","volume":"79","author":"M Zhang","year":"2024","unstructured":"Zhang M, Ma YY, Wang G, Wang ZY, Wang QY, Li X, et al. The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021. J Antimicrob Chemother. 2024;79:526\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"2985_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1089\/aid.2021.0079","volume":"38","author":"QQ Wei","year":"2022","unstructured":"Wei QQ, Zhao Y, Lv YN, Kang X, Pan S, Yao SJ, et al. High rate of HIV-1 drug resistance in antiretroviral therapy-failure patients in Liaoning province, China. AIDS Res Hum Retroviruses. 2022;38:502\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2985_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11080866","volume":"11","author":"S Zheng","year":"2022","unstructured":"Zheng S, Wu JJ, Hao JJ, Wang D, Hu ZW, Liu L, et al. Epidemic characteristics of HIV drug resistance in Hefei, Anhui Province. Pathogens. 2022;11:866.","journal-title":"Pathogens"},{"key":"2985_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11684-020-0756-y","volume":"14","author":"XX Han","year":"2020","unstructured":"Han XX, Zhao B, An MH, Zhong P, Shang H. Molecular network-based intervention brings us closer to ending the HIV pandemic. Front Med. 2020;14:136\u201348.","journal-title":"Front Med"},{"key":"2985_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/QAD.0b013e32831d2a81","volume":"23","author":"DM Smith","year":"2009","unstructured":"Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, Kosakovsky Pond SL, et al. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS. 2009;23:225\u201332.","journal-title":"AIDS"},{"key":"2985_CR23","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2018.1513","volume":"319","author":"AM Oster","year":"2018","unstructured":"Oster AM, France AM, Mermin J. Molecular epidemiology and the transformation of HIV prevention. JAMA. 2018;319:1657\u20138.","journal-title":"JAMA"},{"key":"2985_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/00002030-200403260-00002","volume":"18","author":"S Hu\u00e9","year":"2004","unstructured":"Hu\u00e9 S, Clewley JP, Cane PA, Pillay D. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS. 2004;18:719\u201328.","journal-title":"AIDS"},{"key":"2985_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/v15102053","volume":"15","author":"DF Yuan","year":"2023","unstructured":"Yuan DF, Liu SS, Ouyang F, Ai W, Shi LE, Liu XY, et al. Prevention and control are not a regional matter: a spatial correlation and molecular linkage analysis based on newly reported HIV\/AIDS patients in 2021 in Jiangsu, China. Viruses. 2023;15:2053.","journal-title":"Viruses"},{"key":"2985_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1241-1","volume":"17","author":"D Paraskevis","year":"2019","unstructured":"Paraskevis D, Beloukas A, Stasinos K, Pantazis N, Mendoza CD, Bannert N, et al. HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors. BMC Med. 2019;17:4.","journal-title":"BMC Med"},{"key":"2985_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/aje\/kws436","volume":"177","author":"R Brookmeyer","year":"2013","unstructured":"Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol. 2013;177:264\u201372.","journal-title":"Am J Epidemiol"},{"key":"2985_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198005","volume":"13","author":"XF Wang","year":"2018","unstructured":"Wang XF, Liu XS, Li F, Zhou H, Li JF, Wang YY, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, Northern China, 2014\u20132015. PLoS ONE. 2018;13:e0198005.","journal-title":"PLoS ONE"},{"key":"2985_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku739","volume":"42","author":"D Struck","year":"2014","unstructured":"Struck D, Lawyer G, Ternes AM, Schmit JC, Bercoff DP. COMET: adaptive context-based modeling for ultrafast HIV-1 subtypes identification. Nucleic Acids Res. 2014;42:e144.","journal-title":"Nucleic Acids Res"},{"key":"2985_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.604993","volume":"11","author":"MC Liu","year":"2020","unstructured":"Liu MC, Han XX, Zhao B, An MH, He W, Wang Z, et al. Dynamics of HIV-1 molecular networks reveal effective control of large transmission clusters in an area affected by an epidemic of multiple HIV subtype. Front Microbiol. 2020;11:604993.","journal-title":"Front Microbiol"},{"key":"2985_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00683-20","volume":"94","author":"B Vrancken","year":"2020","unstructured":"Vrancken B, Zhao B, Li XG, Han XX, Liu HZ, Zhao J, et al. Comparative circulation dynamics of the five main HIV types in China. J Virol. 2020;94:e00683\u201320.","journal-title":"J Virol"},{"key":"2985_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jinf.2020.09.007","volume":"81","author":"XR Wang","year":"2020","unstructured":"Wang XR, Zhao J, Li X, Li HP, Zhang Y, Liu YJ, et al. Identification of a novel HIV-1 second-generation circulating recombinant form CRF109_0107 in China. J Infect. 2020;81:816\u201346.","journal-title":"J Infect"},{"key":"2985_CR33","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s00705-021-05213-9","volume":"166","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Y, Wang HY, Liu L, Chen H, Zhang SH, et al. The first third-generation HIV-1 circulating recombinant form (CRF114_0155) identified in central China. Arch Virol. 2021;166:3409\u201316.","journal-title":"Arch Virol"},{"key":"2985_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.meegid.2019.04.024","volume":"73","author":"CY Zhang","year":"2019","unstructured":"Zhang CY, Feng Y, Gao L, Zhang M, Miao J, Dong XQ, et al. Genetic characterization and recombinant history of a novel HIV-1 circulating recombinant form (CRF101_01B) identified in Yunnan, China. Infect Genet Evol. 2019;73:109\u201312.","journal-title":"Infect Genet Evol"},{"key":"2985_CR35","first-page":"612","volume":"79","author":"X Li","year":"2019","unstructured":"Li X, Wu JJ, Zhang Y, Shen YL, Li HP, Xing H, et al. Characterization of a novel HIV-1 second-generation circulating recombinant form (CRF102_0107) among men who have sex with men in Anhui, China. J Infect. 2019;79:612\u201325.","journal-title":"J Infect"},{"key":"2985_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230779","volume":"15","author":"JR Ye","year":"2020","unstructured":"Ye JR, Hao MQ, Xing H, Wang YC, Wang J, Feng Y, et al. Characterization of subtypes and transmitted drug resistance strains of HIV among Beijing residents between 2001\u20132016. PLoS ONE. 2020;15:e0230779.","journal-title":"PLoS ONE"},{"key":"2985_CR37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1017\/S0950268817003016","volume":"146","author":"YX Song","year":"2018","unstructured":"Song YX, Xin RL, Li ZC, Yu HW, Lun WH, Ye J, et al. Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing. Epidemiol Infect. 2018;146:399\u201344.","journal-title":"Epidemiol Infect"},{"key":"2985_CR38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.46234\/ccdcw2023.129","volume":"5","author":"X Liu","year":"2023","unstructured":"Liu X, Wang D, Hu J, Song C, Liao LJ, Feng Y, et al. Changes in HIV-1 subtypes \/ sub-subtypes, and transmitted drug resistance among ART-na\u00efve HIV-infected individuals-China, 2004\u20132022. China CDC Wkly. 2023;5:664\u201371.","journal-title":"China CDC Wkly"},{"key":"2985_CR39","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/jac\/dky561","volume":"74","author":"B Su","year":"2019","unstructured":"Su B, Zheng X, Liu Y, Liu LF, Xin RL, Lu HY, et al. Detection of pretreatment minority HIV-1 reverse transcriptase inhibitor-resistant variants by ultra-deep sequencing has a limited impact on virological outcomes. J Antimicrob Chemother. 2019;74:1408\u201316.","journal-title":"J Antimicrob Chemother"},{"key":"2985_CR40","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1128\/AAC.00714-06","volume":"50","author":"DB Florence","year":"2006","unstructured":"Florence DB, Ava A, Bluma B, Tendani G, Madisa M, Simani G, et al. High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrob Agents Chemother. 2006;50:4182\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"2985_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1510916","volume":"15","author":"XL Lu","year":"2025","unstructured":"Lu XL, Li Y, Liu M, Wang YY, An N, Sun DD, et al. Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018\u20132022. Front Cell Infect Microbiol. 2025;15:1510916.","journal-title":"Front Cell Infect Microbiol"},{"key":"2985_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29937","volume":"96","author":"SY Lv","year":"2024","unstructured":"Lv SY, Lan Y, He YZ, Li QM, Ling XM, Li JB, et al. Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China. J Med Virol. 2024;96:e29937.","journal-title":"J Med Virol"},{"key":"2985_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14040336","volume":"14","author":"QQ Su","year":"2025","unstructured":"Su QQ, Li YJ, Huang T, Wei LJ, He JF, Huang YM, et al. The prevalence of pretreatment drug resistance and transmission networks among newly diagnosed HIV-1-infected individuals in Nanning, Guangxi, China. Pathogens. 2025;14:336.","journal-title":"Pathogens"},{"key":"2985_CR44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1089\/aid.2020.0056","volume":"36","author":"R Zeng","year":"2020","unstructured":"Zeng R, Ren DD, Gong XW, Wei M, Gao LY, Yu AP, et al. HIV-1 genetic diversity and high prevalence of pretreatment drug resistance in Tianjin, China. AIDS Res Hum Retroviruses. 2020;36:852\u201361.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2985_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2373105","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Ma YY, Wang ZY, Wang G, Wang QY, Li X, et al. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017\u20132021. Virulence. 2024;15:2373105.","journal-title":"Virulence"},{"key":"2985_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05007-5","volume":"20","author":"YJ Liu","year":"2020","unstructured":"Liu YJ, Zhang Y, Li HP, Wang XL, Jia L, Han JW, et al. Natural presence of the V179D and K103R\/ V179D mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains. BMC Infect Dis. 2020;20:313.","journal-title":"BMC Infect Dis"},{"key":"2985_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/AAC.50.1.351-354.2006","volume":"50","author":"NT Parkin","year":"2006","unstructured":"Parkin NT, Gupta S, Chappey C, Petropoulos CJ. The K101P and K103R\/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2006;50:351\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"2985_CR48","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. January 2018. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-18.51. Accessed 30 July 2024."},{"key":"2985_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02193-x","volume":"20","author":"H Hong","year":"2023","unstructured":"Hong H, Tang CL, Liu YH, Jiang HB, Fang T, Xu GZ. HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV\/AIDS in Ningbo, China between 2018 and 2021. Virol J. 2023;20:233.","journal-title":"Virol J"},{"key":"2985_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4836-z","volume":"20","author":"SJ Li","year":"2020","unstructured":"Li SJ, Ouyang JM, Zhao B, An MH, Wang L, Ding HB, et al. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains. BMC Infect Dis. 2020;20:123.","journal-title":"BMC Infect Dis"},{"key":"2985_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797771","volume":"12","author":"B Zhao","year":"2022","unstructured":"Zhao B, Song W, Kang MM, Dong X, Li X, Wang L, et al. Molecular network analysis reveals transmission of HIV-1 drug-resistant strains among newly diagnosed HIV-1 infections in a moderately HIV endemic city in China. Front Microbiol. 2022;12:797771.","journal-title":"Front Microbiol"},{"key":"2985_CR52","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","volume":"46","author":"DS Clutter","year":"2016","unstructured":"Clutter DS, Jordan MR, Bertagnolio S, Shafer RW. HIV-1 drug resistance and resistance testing. Infect Genet Evol. 2016;46:292\u2013307.","journal-title":"Infect Genet Evol"},{"key":"2985_CR53","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1080\/22221751.2021.1978822","volume":"10","author":"ZW Ge","year":"2021","unstructured":"Ge ZW, Feng Y, Zhang H, Rashid A, Zaongo SD, Li K, et al. HIV-1 CRF07_BC transmission dynamics in china: two decades of national molecular surveillance. Emerg Microbes Infect. 2021;10:1919\u201330.","journal-title":"Emerg Microbes Infect"},{"key":"2985_CR54","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/infdis\/jiae302","volume":"230","author":"JR Ye","year":"2024","unstructured":"Ye JR, Lan Y, Wang J, Feng Y, Lin Y, Zhou Y, et al. Improvement in the 95-95-95 targets is accompanied by a reduction in both the human immunodeficiency virus transmission rate and incidence in China. J Infect Dis. 2024;230:1202\u201314.","journal-title":"J Infect Dis"},{"key":"2985_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22927","volume":"9","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Lu J, Zhang Z, Sun Q, Xu XQ, Hu HY. Characteristics of the different HIV-1 risk populations based on the genetic transmission network of the newly diagnosed HIV cases in Jiangsu, Eastern China. Heliyon. 2023;9:e22927.","journal-title":"Heliyon"},{"key":"2985_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-242","volume":"11","author":"EP Chow","year":"2011","unstructured":"Chow EP, Wilson DP, Zhang L. What is the potential for bisexual men in China to act as a bridge of HIV transmission to the female population? Behavioral evidence from a systematic review and meta-analysis. BMC Infect Dis. 2011;11:242.","journal-title":"BMC Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02985-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02985-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02985-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:04:30Z","timestamp":1762524270000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02985-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2985"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02985-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study conformed to the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Youan Hospital (approval number: 2024\u2009\u2212\u2009100). The Ethics Committee Board waived the requirement for written informed consent because this was a retrospective study, and all individuals data were analyzed anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}